Home » Topics » Regulatory

Regulatory
RSS

Subcutaneous MabThera approved in Europe for two forms of NHL

March 31, 2014

Albiglutide approved in Europe for type 2 diabetes

March 27, 2014

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Tofogliflozin hydrate approved for type 2 diabetes in Japan

March 26, 2014

Kaketsuken announces Japanese approval of cell culture pandemic influenza vaccine

March 26, 2014

Japanese approval of Lusefi for type 2 diabetes

March 25, 2014

Takelda combination tablets approved in Japan

March 25, 2014

Ajinomoto Pharmaceuticals obtains approval for valsartan/cilnidipine combination in Japan

March 25, 2014

New influenza treatment Avigan approved in Japan

March 25, 2014

NDA for Zacras fixed-dose combination tablet for hypertension approved in Japan

March 25, 2014

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...